XII Congreso Nacional de Virología

Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León

29 de septiembre al 2 de octubre del 2021
Programa Científico

WEBINARS PRE-CONGRESO
Fecha Hora Ponente Tema

Dra. Elizabeth Loza Rubio

25 de agosto 5:00 pm Centro Nacional de Investigaciones Disciplinarias en Viroma
Microbiología Animal - INIFAP

Dra. Ana María Guadalupe Rivas Estilla

8 de septiembre 5:00 pm Desarrollo de la Virología Molecular del
Ciencias Médicas y de Salud Facultad de Medicina -
VHC en México.
UANL
Dr. Víctor Manuel Neira Ramírez
22 de septiembre 5:00 pm Transmisión Interspecies humano- cerdo de
Facultad de Ciencias Veterinarias y Pecuarias
virus influenza A
Universidad de Chile
*Horario Central de México

MIÉRCOLES 29 DE SEPTIEMBRE
Hora Sesión 1: Antivirales y vacunas
9:00 – 9:30 Bienvenida
Conferencia Plenaria Vacunas para coronavirus humanos altamente patogénicos basados en
9:30 – 10:15
Dr. Luis Enjuanes replicones RNA
 Centro Nacional de Biotecnología (CSIC).
Madrid, España.
10:15 – 10:30 AV 01 - Earvin Jey Hernández Guzmán Nucleolin a negative regulator of rotavirus replicative cycle.
Cacalol and cacalol acetate serquiterpenes: cytotoxic, antiproliferative,
10:30 – 10:45 AV 02 - Erick Fernando Aguilar Llanos
and pro-apoptotic activity in cervical carcinoma cell lines.
Detection of human antibodies with a dengue virus E protein epitope
10:45 – 11:00 AV 03 - Gilma Guadalupe Sánchez Burgos associated with mild disease: identification of a potential candidate for
vaccine development.
The entry blocker peptide expressed in microalgae as an Influenza
11:00 – 11:15 AV 04 - Karen Lizbeth Reyes Barrera
replication inhibitor.
The antimicrobial peptide Elafin reduce the ZIKV infectión in the
11:15 – 11:30 AV 05 - Luis Didier González García
trophoblastic cell line JEG3.
Evaluation of the antiviral activity of crude extracts of seaweed from the
11:30 – 11:45 AV 06 - Luis Fernando Ayuso Pino
Yucatan Peninsula against influenza A(H1N1) pdm09 virus.
Glycyrrhizinic acid liposomes increase immune response effectiveness of
11:45 – 12:00 AV 07 - María Azucena Castañeda Montes
small ruminant lentivirus P25 recombinant protein.
Identification and molecular mechanism description of small peptides that
12:00 – 12:15 AV 08 - Mariana Andrade-Medina specifically inhibit the formation of the initiation homodimer of the
Cowpea Chlorotic Mottle Virus capsid.
12:15 – 12:30 AV 09 - Rodrigo Jácome Ramírez Sofosbuvir as a potential alternative to treat the COVID-19.
12:30 – 12:45 AVI 04 - Catalina Ignacia Aguilera Flores Processing of the neurotropic astrovirus VA1 capsid protein precursor.

Hora Sesión 2: Interacción virus – célula

Conferencia Plenaria
2:00 – 2:45 Walther Mothes, PhD. Imaging retroviruses and SARS-CoV-2 across spatial and temporal scales.
Yale School of Medicine, USA.
 Dra. Paloma Rossana Hidalgo Ocampo
2:45 – 3:00 Centro de Investigación en Ciencias Básicas y
Aplicadas, UAEM, México.
3:00 – 3:15 AV 10 - Uriel Enrique Aquino Ruiz
3:15 – 3:30 AV 11 - Carlos Noe Farfán-Morales
3:30 – 3:45 VC 12 - Aldo Román Camacho Zarco
3:45 – 4:00 VC 13 - Arturo Barbachano-Guerrero
4:00 – 4:15 VC 14 - Daniel Ortega Bernal
4:15 – 4:30 VC 15 - Fernanda Guerrero Bravo Piña
4:30 – 4:45 VC 16 - Gerson Isaac Caraballo Hernandez
4:45 – 6:00 Sesión de Carteles
*Horario Central de México
The adenoviral E1B 55K oncoprotein, when less is not more.
Chikungunya virus infection is strongly inhibited by U1 in vitro.
The antiviral Effect of Metformin on Zika and Dengue virus.
Molecular basis of host-adaptation interactions between influenza virus
polymerase PB2 subunit and ANP32A.
Population level diversity in gorilla CD4 influences susceptibility to
cross-species transmission of chimpanzee SIVs.
An approach to cellular tropism of SARS-CoV-2 through bioinformatic
analysis.
The effect of cultured supernants of macrophages persistently infected
with human respiratory syncytial virus (RSV) on a culture of unfected
macrophages.
The dengue virus non-structural protein 1 (NS1) modify the expression of
immune pathways through DIDO1 interactions.

JUEVES 30 DE SEPTIEMBRE
Hora Sesión 3: Epidemiología y Zoonosis
Conferencia Plenaria
9:00 – 9:45 Dr. Carlos F. Arias Epidemiología genómica de SARS-CoV-2 en México
Instituto de Biotecnología, UNAM, México.
Two strains of a geminivirus encoding Rep proteins with identical β1-
9:45 – 10:00 VC 17 - Jesús Aarón Avalos Calleros
strands but different β5-strands are not compatible in replication.
Role of HPV16 E1 protein in epigenetics regulation: post-translational
10:00 – 10:15 VC 18 - José Eduardo Pérez Aquino
modification of the histone tail.
 Understanding plant-virus interaction: the case of Pepper Huasteco yellow
10:15 – 10:30 VC 19 - Joshio Josué Meléndez Graciano
vein virus (PHYVV).
Human Papillomavirus type 16 E6 oncoprotein interacts with CD36
10:30 – 10:45 VC 20 - Katia Monstserrat Ramírez Alcántara
receptor and regulates its expression in head and neck cancer.
10:45 – 11:00 VC 21 - Luis Eduardo Jiménez Martínez Role of the proteasome in the replicative cycle of astrovirus.
Effect of fatty acids and cholesterol levels on CHIKV and ZIKV
11:00 – 11:15 VC 22 - Mayra Meléndez Villanueva
replication.
Cytotrophoblastic cells seem to play a critical role for the invason of the
11:15 – 11:30 VC 23 - Mercedes Isabel Viettri Pinto
Zika virus to the placental stroma.
Adenovirus replication compartments. Biomolecular condensates with
11:30 – 11:45 VC 24 - Ramón A. González
liquid properties.
Analysis of the transcriptional activity of TAF1 induced by HPV16 E2
11:45 – 12:00 VC 25 - Sofía Luna García
expression and its relationship with TP53 status.
Characterization of rotavirus mutants with changes in the non-structural
12:00 – 12:15 VC 26 - Viviana Andrea Barragán Torres
protein NSP3.
Regulation of the Type I Interferon pathway in human immune cells by
12:15 – 12:30 VC 27 - María Leticia Ávila-Ramírez
Dengue virus.

Hora Sesión 4: Evolución viral

Conferencia Plenaria
José Regla Nava PhD.
2:00 – 2:45 Enfermedades emergentes y reemergentes: Dengue y Zika
LJI, California, USA Universidad de
Guadalajara, CUCS, México.
Dr. José Manuel Reyes Ruiz Centro de Estudio de la interacción virus – hospedero: implicaciones de la
2:45 – 3:00 Investigación y de estudios avanzados del adaptación, infección y diseminación del virus Dengue en células de su
Instituto Politécnico Nacional, México. mosquito vector.
 Data mining as a tool to associate plant viral sequences with symptoms
3:00 – 3:15 EV 28 - Enrique Alejandro Guevara Rivera
development.
Current and potential geographic distribution of Aedes leucocephalus, the
3:15 – 3:30 EZ 29 - Antonio Acini Vásquez Aguilar
principal vector of sylvatic dengue virus in Africa.
Detection of Norovirus, Hepatitis A and Rotavirus in Vegetables and
3:30 – 3:45 EZ 30 - Axel Alejandro Ossio Rodriguez Their Correlation with the Presence of Somatic Coliphages as Viral
Contamination Indicators.
The protective effect of house-screening against indoor Aedes aegypti in
3:45 – 4:00 EZ 31 - Henry Puerta-Guardo
Mérida, Mexico: a cluster randomized controlled trial.
Viral etiological agent detection for coastal ecosystems health monitoring
4:00 – 4:45 EZ 32 - Joanna María Ortiz Alcántara
in Sisal, Yucatan, Mexico.
Human papillomavirus infection in the oral cavity of patients from
4:45 – 5:00 EZ 33 - José Guadalupe Rendón Maldonado
Culiacan, Sinaloa.
Conferencia Plenaria
5:00 – 5:45 Edward Holmes PhD. Zoonoses and origin, emergence and evolution of SARS-CoV-2
University of Sydney, Australia, Sydney.
Characterization of M and NP recombinant proteins from Porcine
5:45 – 6:00 EZ 34 - José Luis Cerriteño Sánchez
Rubulavirus.
*Horario Central de México

VIERNES 1° DE OCTUBRE
Hora Sesión 5: Respuesta inmune contra virus
Conferencia Plenaria
Dr. Adolfo García-Sastre
9:00 – 9:45 Global Health and Emerging Pathogens Interacciones virus-huésped en SARS-CoV-2
Institute of Icahn School of Medicine at
Mount Sinai. New York, USA.
 Detection of FeLV regressive infections in cats of Mérida, Yucatán with
9:45 – 10:00 EZ 35 - María Casandra Canto Valdés
clinical signs and related hematological alterations.
Frequency and distribution of HPV in samples of men and women from
10:00 – 10:15 EZ 36 - María de Jesús Arias
Sinaloa.
Association of adenovirus 36 with low-grade inflammation in human
10:15 – 10:30 EZ 37 - María de la Luz Karina Reyes Olivas
adipose tissue.
Longitudinal study of HPV infection in the oral mucosa from people
10:30 – 10:45 EZ 38 - Neybi Esther Carvajal Kú
living with HIV/AIDS.
Natural arbovirus infection rate and detectability of indoor female Aedes
10:45 – 11:00 EZ 39 - Oscar David Kirstein
aegypti from Mérida, Yucatán, Mexico.
Characterization of two rabies virus variants in white-nosed coatis (Nasua
11:00 – 11:15 EZ 40 - Karla Paola Puebla Rodriguez narica) from Yucatan and Quintana Roo (2007-2020): Are coatis
emergent reservoirs of rabies virus in Mexico?
Detection of genotype 45 human papillomavirus as an emerging infection
11:15 – 11:30 EZ 41 - Alejandra Paola Martínez Camberos
in Mexican women.
Anti-SARS-CoV-2 IgG levels in child population of Nayarit, Mexico as a
11:30 – 11:45 EZ 42 - Gladys Alejandra Toledo Ibarra community immunity biomarker: A 17-month follow-up case study of the
COVID-19 pandemic.
Characterization of prophages present in clinical isolates of Acinetobacter
11:45 – 12:00 EZ 43 - Itzel Abigail Hernández Reyna
baumannii from the National Institute of Rehabilitation.
Surveillance of seasonal respiratory viruses among Chilean patients
12:00 – 12:15 EZ 44 - Luis Antonio Alonso Palomares
during the COVID-19 pandemic in 2020.
Absence of CD43 results in diminished mortality and lung injury in
12:15 – 12:30 RI 45 - Alicia Helena Márquez Bandala
Influenza virus infection.

Hora Sesión 6: Viroma

 Conferencia Plenaria
Dra. Marina Gallo Calderón
Caracterización molecular de cepas de Parvovirus y Virus Distemper
2:00 – 2:45 Instituto de Ciencia y Tecnología Dr. Cesar
Canino circulantes en Argentina
Milstein – CONICET. Buenos Aires,
Argentina.
Dr. José Alberto Campillo Balderas Origen y evolución temprana de los virus y su relación con el último
2:45 – 3:00
Facultad de Ciencias, UNAM, México. ancestro común de los seres vivos
Antibody responses against SARS-CoV-2 among healthcare risk groups
3:00 – 3:15 RI 46 - Julio Andrés Batún Alfaro
and general population of Mérida, Yucatan: A retrospective study.
3:15 – 3:30 RI 47 - Karen Rocío Villaseñor Zepeda Antiviral response genes expression in COVID-19 hospitalized patients.
Increase of Soluble TNFR1 and ADAM17 correlates to mortality in
3:30 – 3:45 RI 48 - Yadira Palacios Rodríguez
patients with severe COVID-19.
Immunometabolic Signatures Predict Risk of Progression to Sepsis in
3:45 – 4:00 RI 49 - Yamile López Hernández
COVID-19.
Effects of Zika virus infection in human neural precursor cells depend on
4:00 – 4:15 RI 50 - Edson Iván Rubio Hernández
their differentiation state.
Rotavirus VP6 targeted to dec-205 induces a strong protection against the
4:15 – 4:30 RI 51 - Omar Velázquez-Sánchez
infection when administered parenterally or in mucosa.
High prevalence and diversity of Caliciviruses in a community setting
4:30 – 4:45 V 52 - Xaira Jimena Rivera Gutiérrez
determined by a metagenomic approach.
4:45 – 6:00 Sesión de Carteles
*Horario Central de México

SÁBADO 2° DE OCTUBRE
Hora Mesas Redondas
Dr. Arturo Reyes Sandoval
9:30 Vacunas contra COVID-19
Director General Instituto Politécnico
Nacional, México.
 Dr. Adolfo García-Sastre
Global Health and Emerging Pathogens
Institute of Icahn School of Medicine at
Mount Sinai. New York, USA.

Dr. Constantino López-Macías

Hospital de Especialidades. Centro Médico
Nacional Siglo XXI – IMSS

Dra. Montserrat Torremorell

Department of Veterinary Population Medicine.
University of Minnesota, USA.

Dra. Gloria Ramírez Nieto

Facultad de Medicina Veterinaria y de
Zootecnia. Universidad Nacional de Colombia.
11:00 Influenza and Zoonosis
Bogotá, Colombia.

Dra. Agustina Rimondi

Instituto de Virología del Centro de
Investigación. Ciencias Veterinarias y
Agronómicas (CNIA). Buenos Aires,
Argentina.

Sesión de negocios SMV

12:00 – 1:00 3era Asamblea General Ordinaria de la SMV
 Elección del Consejo Directivo de la SMV 2021-2023

*Horario Central de México